CLINICAL_TRIALS
trial_result
· 2020-03-17
Clinical Trial Update: Exemestane and Cyclophosphamide for Metastatic Breast Cancer [Phase 2]
Summary
Phase 2 trial evaluating exemestane and cyclophosphamide for metastatic breast cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NYU Langone Health | Conditions: Metastatic Beast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-03-17